Adverse Events and Serious Adverse Events - Katalyst HLS
-
Upload
katalyst-hls -
Category
Health & Medicine
-
view
202 -
download
11
Transcript of Adverse Events and Serious Adverse Events - Katalyst HLS
Adverse Events &
Serious Adverse Events
1
05/02/23Katalyst Healthcares & Life Sciences
Objectives:
Recognize Adverse Events and Serious Adverse Events Review FDA inspection findings related to Adverse
Events Review regulations related to Adverse Events Discuss recording and reporting of Adverse Events Discuss auditing of Adverse Events Demonstrate audit of Adverse Events
2
05/02/23
Katalyst Healthcares & Life Sciences
FDA Inspection:
“Failure to prepare and submit complete and accurate and timely reports of unanticipated adverse device effects”
3
05/02/23Katalyst Healthcares & Life Sciences
Recognizing:4
05/02/23Katalyst Healthcares & Life Sciences
Adverse Events:
Any adverse event associated with the use of a drug in humans, whether or not considered related. 21CFR 314.80
Any untoward medical occurrence in a patient administered a pharmaceutical product and which does not necessarily have a causal relationship with the treatment ICH E6
5
05/02/23Katalyst Healthcares & Life Sciences
Adverse Event:
NCI An unexpected medical problem that occurs during
treatment with a drug or other therapy. Adverse events do not have to be a caused by the
drug or therapy
6
05/02/23Katalyst Healthcares & Life Sciences
Serious Adverse Event:
Fred Doesn’t Have Any Money Left
FatalDisabilityHospitalizationAnomalyMedically SignificantLife Threatening
7
05/02/23Katalyst Healthcares & Life Sciences
Expected Vs. Unexpected
Expected Known to Occur and
is Listed in the Investigational Brochure, Informed Consent, or General Investigational Plan
Unexpected Not listed in
Investigational Brochure, Informed Consent, or General Investigational Plan
Also not listed in a drug package insert
8
05/02/23Katalyst Healthcares & Life Sciences
Recording:
9
05/02/23Katalyst Healthcares & Life Sciences
Recording:
Know which adverse events the protocol requires to be captured
10
05/02/23Katalyst Healthcares & Life Sciences
Source Documentation:
Source Documentation of adverse events include documentation in the medical records of: Event Date it occurred Grade as determined by CTCAE Expected or Unexpected Attribution as assigned by PI Date resolved Treatment patient received specifically related to event
11
05/02/23Katalyst Healthcares & Life Sciences
Sample Adverse Event Recording Form
See template behind this presentation
12
05/02/23Katalyst Healthcares & Life Sciences
13
05/02/23Katalyst Healthcares & Life Sciences
Attribution (Causality) The attribution (relationship or causality or drug
related assessment) must be determined
A determination made by a clinical investigator that describes the relationship or association of the study product with an adverse experience
This determination must be recorded both in the medical record as well as in the case report form.
14
05/02/23Katalyst Healthcares & Life Sciences
Attribution
What should the investigator consider prior to assigning attribution? Individual medical history Known effects of concomitant medications
15
05/02/23Katalyst Healthcares & Life Sciences
Attribution:
Definite – Clearly related to study agent Probable – Likely related to study agent Possible – May be related to study agent Unlikely – Doubtfully related to study agent Unrelated – Clearly not related to study
agent
16
05/02/23Katalyst Healthcares & Life Sciences
How to Capture Adverse Events?
Split or Lumped Fever, Diarrhea, and Vomiting (Viral
Gastroenteritis) Cough, Sniffles, Sore throat (Flu)
17
05/02/23Katalyst Healthcares & Life Sciences
How to Capture Adverse Events?
Problems with similar terms Rash or Dermatitis Wheezing, reactive airway disease,
congestion, cold, , asthma
18
05/02/23Katalyst Healthcares & Life Sciences
Documenting Resolution Dates:
Challenge Does the patient remember when their adverse
event resolved? Do you call the patient? Or wait till the next visit?
19
05/02/23Katalyst Healthcares & Life Sciences
Patient Toxicity Diary:
Diaries where patients capture toxicities between their follow up appointments
20
05/02/23Katalyst Healthcares & Life Sciences
Patient Toxicity Diaries:
Patient writes down constipation because he did not have a bowel movement one day Research nurse captures constipation without assessing
further Physician copies the research nurse’s note and also dictates
constipation Did anyone ask about the constipation?
According to CTC V3, constipation is grade 1 only if there is occasional or intermittent symptoms; occasional use of stool softeners, laxatives, dietary modification, or enema
21
05/02/23Katalyst Healthcares & Life Sciences
Patient Adverse Event Diaries:
Advantages Allows capturing
information on a daily basis while patient is away from clinic
A communication tool for patient returns to clinic
Useful in capturing onset and resolution dates of adverse events
Disadvantages Time consuming Patient non-compliance Patient self diagnosis or
interpretation Complicated Instructions
22
05/02/23Katalyst Healthcares & Life Sciences
Question to Ask:
When should site staff begin collecting adverse event information?
23
05/02/23Katalyst Healthcares & Life Sciences
Question to Ask:
How long should one collect adverse events after the subject completes study treatment?
24
05/02/23Katalyst Healthcares & Life Sciences
Reporting:25
05/02/23Katalyst Healthcares & Life Sciences
Reporting Serious Events
An investigator must promptly report to the sponsor any adverse effect that may reasonably be regarded as caused by or probably caused by the drug. If the adverse effect is alarming, the investigator shall report the adverse effect immediately. 21CFR312.64
26
05/02/23Katalyst Healthcares & Life Sciences
Reporting Criteria:
Routine Reporting Know which events can be reported at
interim analysis or annual reviews Expedited Reporting
Know which events require immediate reporting
27
05/02/23Katalyst Healthcares & Life Sciences
Reporting Criteria
Know which type of expedited reports each regulatory body requires FDA Sponsor Co-Sponsor MD Anderson NCI Collaborative Groups
28
05/02/23Katalyst Healthcares & Life Sciences
Issues in Reporting:
Primary events Example
Patient admitted with Congestive Heart Failure Subsequently develops: Pulmonary Edema and
Cardiogenic Shock
29
05/02/23Katalyst Healthcares & Life Sciences
Consequences of Improper Reporting
Protocol Violations IRB will close protocol FDA Hold Sponsor Hold Research Privileges Revoked Patient Safety
30
05/02/23Katalyst Healthcares & Life Sciences
Auditing:
31
Auditing Check Points
Was the event a dose limiting toxicity? Should the dose have been reduced? If so, did the research team realize it as such and
identify it correctly?
32
05/02/23Katalyst Healthcares & Life Sciences
Auditing Check Points
How are AEs being recorded in the medical record?
Does documentation include grade, onset, resolution, and attribution?
33
05/02/23Katalyst Healthcares & Life Sciences
Auditing Check Points
Were all toxicities included? Was the proper CTCAE version used for
the protocol? Were the toxicities graded
appropriately?
34
05/02/23Katalyst Healthcares & Life Sciences
Auditing
Are adverse events appropriately reported within the time periods required by regulations, sponsor, and IRB policies?
35
05/02/23Katalyst Healthcares & Life Sciences
We have reviewed……….
Recognizing adverse events and serious adverse events Inspections and findings related to adverse events Regulations related to adverse events Recording and reporting of adverse events Auditing of adverse events
36
05/02/23Katalyst Healthcares & Life Sciences
Thank YouThank You&&
QuestionsQuestions
05/02/23
Contact:Katalyst Healthcare’s & Life SciencesSouth Plainfield, NJ, USA 07080.E-Mail: [email protected]
37